Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Real-life clinical management patterns in extensive-stage small cell lung cancer across France: a multi-method study

Fig. 4

Indications and influencing factors in the participating medical centers for offering thoracic radiotherapy following induction chemoimmunotherapy (A), and dose and fractionation schedules commonly used in thoracic radiotherapy for extensive-stage small cell lung cancer (ES-SCLC) (B). *Other include: aggressive mediastinal mass at ES-SCLC diagnosis; patients with a metastasis in complete remission but showing persistent disease on positron emission tomography

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us